Security key
86150R107
Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK)
CUSIP: 86150R107
Q2 2019 13F Holders as of 30 Jun 2019
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 58,810,778
- Total 13F shares
- 14,232,528
- Share change
- +14,232,528
- Total reported value
- $409,341,450
- Price per share
- $29.17
- Number of holders
- 47
- Value change
- +$409,341,450
- Number of buys
- 47
Report period
Q2 2019
Institutions
47
Top holders
10
STOK full security history
Newer quarter: Q3 2019
Stoke Therapeutics, Inc. SEC filings
Stoke Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 86150R107
Recent filing periods:
Top shareholders of STOK - Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK) as of Q2 2019
As of 30 Jun 2019,
Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,232,528 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, Cormorant Asset Management, LP, GILDER GAGNON HOWE & CO LLC, RA CAPITAL MANAGEMENT, LLC, Redmile Group, LLC, PERCEPTIVE ADVISORS LLC, FMR LLC, MILLENNIUM MANAGEMENT LLC, WELLINGTON MANAGEMENT GROUP LLP, and JANUS HENDERSON GROUP PLC.
This page lists
47
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2019 vs Q4 2025 Across Filers
Q4 2025 holders
183
Q2 2019 holders
47
Holder diff
-136
| Investor | Q4 2025 Shares | Q2 2019 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q2 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.